Journal of Clinical Immunology

, Volume 1, Issue 1, pp 51–63 | Cite as

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

  • Hugh F. Pross
  • Malcolm G. Baines
  • Peter Rubin
  • Peter Shragge
  • Michael S. Patterson
Original Articles

Abstract

On analysis ofin vitro assays of human natural killer (NK) cell function the inadequacy of commonly used methods of expressing lytic activity was apparent. A comparison was made of the data obtained using modifications of two equations—the simple exponential fit and the von Krogh equations. Both of these equations were found to satisfy the following essential criteria for use in these assays. First, the majority of the results obtained in the chromium-release assay could be used in data reduction; second, the resultant “dose-response” curve was reduced to linearity; and third, a single numerical expression was obtained which was directly proportional to the cytotoxic activity. Of the two methods the more conventional exponential fit was found to be the simpler to use. The closeness of fit of the experimentally derived data to the ideal curves did not support the possibility that normal lymphocyte preparations contain suppressor cells capable of inhibiting NK activity. Data have also been presented showing that NK-sensitive targets could be categorized with respect to their susceptibility by comparing the slopes of the target cell survival curves obtained using the exponential fit equation. These observations are relevant to the accurate assessment of NK activity in patient populations and to the determination of the effects of disease and its treatment on this activity.

Key words

Human natural killer cells chromium release 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pross HF, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review. Cancer Immunol Immunother 3:7585, 1977Google Scholar
  2. 2.
    Herberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Puccetti P: Natural killer cells: Characteristics and regulation of activity. Immunol Rev 44:43–70, 1979Google Scholar
  3. 3.
    Baines MG, Pross HF, Millar KG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy. Am J Obstet Gynecol 130:741–744, 1978Google Scholar
  4. 4.
    Pross HF, Wilberforce K, Dean D, Kennedy JC, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VIII. Characteristics of normal lymphocytes showing consistently high or low natural killer (NK) cell activity.In The Molecular Basis of Immune Cell Function, JG Kaplan (ed). Amsterdam, Elsevier/North Holland, 1979, pp 580–584Google Scholar
  5. 5.
    Santoli D, Trinchieri G, Zmijewski CM, Koprowski H: HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol 117:765–770, 1976Google Scholar
  6. 6.
    Hersey P, Edwards A, Honeyman M, McCarthy WH: Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40:113–122, 1979Google Scholar
  7. 7.
    Pross HF, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against target cells. I. The effect of malignant disease. Int J Cancer 18:593–604, 1976Google Scholar
  8. 8.
    Takasugi M, Ramseyer A, Takasugi J: Decline of natural non-selective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res 37:413–418, 1977Google Scholar
  9. 9.
    De Vries JE, Cornain S, Rumke P: Cytotoxicity of non-Tvs T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells. Int J Cancer 14:427–434, 1974Google Scholar
  10. 10.
    Menon M, Stefani SS: Lymphocyte mediated natural cytotoxicity in neoplasia. Oncology 35:3–7, 1978Google Scholar
  11. 11.
    Svedmyr E, Jondal M: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci USA 72:1622–1626, 1975Google Scholar
  12. 12.
    Pross HF, Gupta S, Good RA, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Cell Immunol 43:160–175, 1979Google Scholar
  13. 13.
    Koren HS, Amos DB, Buckley RH: Natural killing in immunodeficient patients. J Immunol 120:796–799, 1978Google Scholar
  14. 14.
    Oshimi K, Gonda N, Sumiya M, Kano S: Natural killer effects of corticosteroids on activity in systemic lupus erythematosus. Clin Exp Immunol 40:83–88, 1980Google Scholar
  15. 15.
    Benczur M, Petranyi GGy, Palffy Gy, Varga M, Talas M, Kotsy B, Foldes I, Hollan SR: Dysfunction of natural killer cells in multiple sclerosis: A possible pathogenetic factor. Clin Exp Immunol 39:657–662, 1980Google Scholar
  16. 16.
    Parrillo JE, Fauci AS: Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-dependent cellular cytotoxicity: Differential sensitivity of effector cells toin vivo andin vitro corticosteroids. Scand J Immunol 8:99–107, 1978Google Scholar
  17. 17.
    Thatcher N, Swindell R, Crowther D: Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. Clin Exp Immunol 35:171–179, 1979Google Scholar
  18. 18.
    Einhorn S, Blomgren H, Strander H: Interferon and spontaneous cytotoxicity in man. Acta Med Scand 204:477–483, 1978Google Scholar
  19. 19.
    Livnat S, Seigneuret M, Storb R, Prentice RL: Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation. J Immunol 124:481–490, 1980Google Scholar
  20. 20.
    Lopez C, Sorell M, Kirkpatrick D, O'Reilly RJ, Ching C: Association between pre-transplant natural kill and graftversus-host disease after stem-cell transplantation. Lancet 2:1103–1107, 1979Google Scholar
  21. 21.
    von Krogh M: Colloidal chemistry and immunology. J Infect Dis 19:452–477, 1916Google Scholar
  22. 22.
    Brunner KT, Manuel J, Cerottini JC, Chapuis B: Quantitative assay of the lytic action of immune lymphoid cells on51Cr-labelled allogeneic target cellsin vitro: Inhibition by isoantibody and by drugs. Immunol 14:181–196, 1968Google Scholar
  23. 23.
    Thorn RM, Henney CS: Kinetic analysis of target cell destruction by effector T cells. I. Delineation of parameters related to the frequency and lytic efficiency of killer cells. J Immunol 117:2213–2219, 1976Google Scholar
  24. 24.
    Zeijlemaker WP, van Oers RHJ, de Goede REY, Schellekens PThA: Cytotoxic activity of human lymphocytes: Quantitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics. J Immunol 119:1507–1514, 1977Google Scholar
  25. 25.
    Callewaert DM, Johnson DF, Kearney J: Spontaneous cytotoxicity of cultured human cell lines mediated by normal peripheral blood lymphocytes. III. Kinetic parameters. J Immunol 121:710–717, 1978Google Scholar
  26. 26.
    Boyum A: Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21 (Suppl 97):77–89, 1968Google Scholar
  27. 27.
    Lundgren G, Zukoski CF, Moller G: Differential effects of human granulocytes and lymphocytes on human fibroblastsin vitro. Clin Exp Immunol 3:817–836, 1968Google Scholar
  28. 28.
    Jondal M, Pross H: Surface markers on human B and T lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer 15:596–605, 1975Google Scholar
  29. 29.
    Pross HF, Baines MG: Natural killer cells in tumor-bearing patients.In Natural Killer Cells, RB Herberman (ed). New York, Academic Press, 1980, in pressGoogle Scholar
  30. 30.
    Perlman D, Rahman SB, Semar JB: Antibiotic control of mycoplasma in tissue culture. Appl Microbiol 15:82–85, 1967Google Scholar
  31. 31.
    Brooks CG, Rees RC, Leach RH: High nonspecific reactivity of normal lymphocytes against mycoplasma-infected target cells in cytotoxicity assays. Eur J Immunol 9:159–165, 1979Google Scholar
  32. 32.
    Lozzio CB, Lozzio BB: Cytotoxicity of a factor isolated from human spleen. J Natl Cancer Inst 50:535–538, 1973Google Scholar
  33. 33.
    Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347–349, 1977Google Scholar
  34. 34.
    Cuthbert D, Wood FS: Fitting Equations to Data. Wiley-Interscience, New York, 1971, Chap 9Google Scholar
  35. 35.
    Sokal RR, Rohlf FJ: Biometry. The Principles and Practice of Statistics in Biological Research. WH Freeman, San Francisco, 1969Google Scholar
  36. 36.
    Miller RG, Dunkley M: Quantitative analysis of the51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol 14:284–302, 1974Google Scholar
  37. 37.
    Dunkley M, Miller RG, Shortman K: A modified51Cr release assay for cytotoxic lymphocytes. J Immunol Methods 6:39–51, 1974Google Scholar
  38. 38.
    Kabat EA, Mayer MM: Experimental Immunochemistry, 2nd ed. Springfield, Ill., CC Thomas Press, 1967Google Scholar
  39. 39.
    MacLennan ICM, Campbell AC, Gale DGL: Quantitation of K cells.In In Vitro Methods in Cell-Mediated and Tumor Immunity, BR Bloom, JR David (eds). New York, Academic Press, 1976, pp 511–522Google Scholar
  40. 40.
    Trinchieri G, De Marchi M, Mayr W, Sari M, Ceppellini R: Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc V:1631–1646, 1973Google Scholar
  41. 41.
    Pross HF, Luk S, Baines MG: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. V. The role of serum-derived heterologous membrane antigens. Int J Cancer 21:291–298, 1978Google Scholar
  42. 42.
    Pross HF, Jondal M: Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 21:226–235, 1975Google Scholar
  43. 43.
    Nunn ME, Herberman RB: Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells. J Natl Cancer Inst 62:765–771, 1979Google Scholar
  44. 44.
    Clark DA, Phillips RA, Miller RG: Characterization of cells that suppress the cytotoxic activity of T lymphocytes. I. Quantitative measurement of inhibitor cells. J Immunol 116:1020–1029, 1976Google Scholar
  45. 45.
    Pross HF, Baines MG: Characteristics of human natural killer cells.In Natural Killer Cells, RB Herberman (ed). New York, Academic Press, 1980, in pressGoogle Scholar
  46. 46.
    Oldham RK, Djeu JY, Cannon GB, Siwarski D, Heberman RB: Cryopreservation of human lymphocyte function as measured byin vitro assays. Int J Cancer 18:145–155, 1976Google Scholar
  47. 47.
    Herberman RB, Nunn ME, Holden HT: Statistical Analysis and selection of baseline controls in cytotoxicity assays.In In Vitro Methods in Cell-Mediated and Tumor Immunity, BR Blood, JR David (eds). New York, Academic Press, 1976, pp 481–488Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • Hugh F. Pross
    • 1
  • Malcolm G. Baines
    • 2
  • Peter Rubin
    • 3
  • Peter Shragge
    • 4
  • Michael S. Patterson
    • 4
  1. 1.Departments of Radiation Oncology and Microbiology & ImmunologyQueen's UniversityKingstonCanada
  2. 2.Departments of Microbiology & Immunology and Obstetrics & GynecologyQueen's UniversityKingstonCanada
  3. 3.Department of Microbiology & ImmunologyQueen's UniversityKingstonCanada
  4. 4.Department of Radiation OncologyQueen's UniversityKingstonCanada

Personalised recommendations